Considered a pipe dream not too long ago, research on RNA therapeutics is progressing rapidly. Now a new manufacturing protocol will help researchers to advance the technology.
Academic rigor, journalistic flair
Articles on Messenger RNA
Displaying all articles
For the first time, the drug substance, or active ingredient for a COVID-19 vaccine - in this case mRNA - will be manufactured on the continent.
In the spotlight for its role in COVID-19 vaccines – and a Nobel Prize – mRNA is not a new invention. It’s a crucial messenger molecule at work every day in every cell in your body.
With slow vaccine distribution and manufacturing, some people won’t get the second dose on time. But does it matter?
Two pharma companies have announced early COVID-19 vaccine trial results with over 90 per cent effectiveness. What does that mean for getting back to normal?
Aging and cancer appear to be closely linked, as over time, cells accumulate hits in their DNA code. But now research has turned to the role of RNA. Is RNA the key to a longer life?
Top contributors
-
Professor of Technology Management, University of Pretoria
-
Postdoctoral Associate in Biomedical Sciences, Cornell University
-
Professor of Medicine, University of Virginia
-
Postdoctoral fellow, McGill University
-
Associate Professor of Functional Genomics, Texas A&M University
-
Senior Specialist in Molecular Biology, Malaghan Institute of Medical Research
